Sostdc1: a Bmp/Wnt Dual Pathway Antagonist in Breast and Renal Cancers
Total Page:16
File Type:pdf, Size:1020Kb
SOSTDC1: A BMP/WNT DUAL PATHWAY ANTAGONIST IN BREAST AND RENAL CANCERS BY KIMBERLY ROSE BLISH A Dissertation Submitted to the Graduate Faculty of WAKE FOREST UNIVERSITY GRADUATE SCHOOL OF ARTS AND SCIENCES in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY Molecular Medicine and Translational Science May 2009 Winston-Salem, North Carolina Approved By: Suzy V. Torti, Ph.D. Advisor ________________________________ Examining Committee: Mark C. Willingham, M.D., Chairman ________________________________ Gregory A. Hawkins, Ph.D. ________________________________ Raymond Penn, Ph.D. ________________________________ William Jeffrey Petty, M.D. ________________________________ ACKNOWLEDGEMENTS At the end of a long research and writing process, I come at last to the part where I can reflect upon the journey with gratitude. However, as I am typing these words last, I am hampered by a diminished vocabulary and I know I shall fall short on the most important words of the document! To all whom I salute below: I sincerely could not have accomplished anything worthwhile without you. These words will not do you justice for your support has meant the world to me. This project would be nonexistent without the opportunities, guidance, and experience offered from my advisor, Suzy Torti and co-advisor, Frank Torti. You both challenged me to become a better scientist. I am indebted to you for giving me and my ideas a “home” for the past 5 years. I am grateful to my committee members (Mark Willingham, Greg Hawkins, Anthony Atala, Ray Penn, Jeff Petty) and many other faculty collaborators who took my ideas seriously, encouraged new directions, and gave of their time and laboratory resources. I have acknowledged specific contributions where appropriate throughout the text. Mark Willingham, Tim Kute, Greg Hawkins, and members of their laboratories were colleagues with indispensible aid and inexhaustible advice. The entire Torti Lab contributed through advice, technical assistance, and at times, “colleague commiseration”. Particular mention goes to Samer Kalakish, ii Matt Triplette, Wei Wang, Seon-Hi Jang, Lan Coffman, Zandra Pinnix, Alice Mims, and Jonathan Storey for their direct contributions to this project. All students rely heavily on laboratory technicians and I was no exception. My thanks especially go to Rong Ma and Julie Brown for keeping the lab running smoothly, yet finding time to teach and answer endless questions. I am particularly indebted to Julie Brown for her hours of support, technical, moral, and spiritual on this project. I would not have arrived at Wake Forest in the first place without a lot of help. I had not considered a PhD degree until the mentoring I received in college from Lowell Hall and Cynthia Davis, both of whom invested in me – not only as one of their students, but as a person. Mark Payne, David Bass, Cash McCall, Jamal Ibdah, Paul Laurienti, Linda McPhail, Bridget Brosnihan, and Kevin High in the Molecular Medicine and MD/PhD programs provided career and administrative support during my transition into and throughout the dual-degree program. I have had the honor of working with an incredibly high caliber of colleagues in the Molecular Medicine, MD/PhD, and Cancer Biology programs and I am proud to be part of these departments. Personally, there was a formidable army of friends and family who would not let me back down and were constantly rooting for me including: • My prayer partners and cheerleaders- may you be abundantly blessed! iii • My extended family at Harvest Point Church, especially the youth group who tried to keep me smiling through it all. • The cancer survivors who shared their stories and their enthusiasm for life: Susan Blish, Kate Hacker, and Bob Smith • The Rose, Pomante, Smith, Blish, LaBarr, and Stotler families for understanding my preoccupation, missed holidays, and late birthday cards and forgiving me when finishing this thesis work became overwhelming. At the end, I couldn’t have made it without the support network that helped sustain me day to day (and provided excellent child care)! • Mom and Dad- There are no better examples of self-sacrificing love and support than you. I am the person I am, having achieved these things- because of you. When the battle was long, you held up my arms. • My husband, Drew. You have put up with everything you promised and more! “Time after Time.” I can’t imagine anyone else I’d rather share this with. I dedicate this work to: Evelyn Smith & Elaine Rose, because I am in awe of all that has been done, Drew, because every day is worth it, and Ethan, because there’s hope for the future. Glory to the One who was, and is, and is to come (Revelations 1:8) iv TABLE OF CONTENTS Page LIST OF ABBREVIATIONS ………………………………………………….. vi LIST OF ILLUSTRATIONS …………………………………………………... xi ABSTRACT…………………………………………………………………….. xiv Chapter I. INTRODUCTION: BMP/WNT PATHWAYS SIGNALING IN CANCER AND SOSTDC1 AS A POTENTIAL DUAL-PATHWAY INHIBITOR……………………………………………………………….. 1 II. THE HUMAN BONE MORPHOGENETIC PROTEIN ANTAGONIST SOSTDC1 IS DOWNREGULATED IN RENAL CANCERS Published in Molecular Biology of the Cell, February 2008…………. 39 III. LOSS OF HETEROZYGOSITY AFFECTING SOSTDC1 IN RENAL TUMORS For Submission to Cancer Epidemiology Biomarkers and Prevention ……………………………………………………………….. 77 IV. SOSTDC1, AN ANTI-PROLIFERATIVE BMP ANTAGONIST, IS POORLY EXPRESSED IN PATIENTS WITH ADVANCED BREAST CANCER In Preparation…………………………………………………………….. 106 V. GENERAL DISCUSSION……………………………………………….. 142 SCHOLASTIC VITA……………………………………………………………. 167 v LIST OF ABBREVIATIONS AHR Aryl Hydrocarbon Receptor AKT Akt/Protein Kinase B Oncogene Family APC Adenomatous Polyposis Coli ALK Activin-Like Kinase AUS Antigen Unmasking Solution BHD Birt-Hogg-Dubé BMP Bone Morphogenetic Protein BMPA BMP Antagonist BMPR BMP Receptor CCN Family of proteins including: CTGF, cyr61, and nov CEU Population of Utah residents with northern or western European ancestry (HapMap designation) CK-1,-2 Casein kinase-1, -2 CTCK C-Terminal Cystine Knot CTGF Connective Tissue Growth Factor Cyr61 Cysteine rich 61 DAN Differential screening-selected gene Aberrative in Neuroblastoma DCIS Ductal Carcinomas In Situ (Breast) DSH/DVL Disheveled DKK Dickkopf vi EGF/R Epidermal Growth Factor/Receptor FBS Fetal Bovine Serum FGF Fibroblast Growth Factor FH Fumerate Hydratase FWT Familial Wilms Tumor locus FRZ Frizzled FSH Follicle Stimulating Hormone GAPDH GlycerAldehyde-3-Phosphate DeHydrogenase GSK-3β Glycogen synthase kinase-3β HapMap International HapMap Project- partnership to database of frequencies of human SNPs hCG human Chorionic Gonadotropin HMEC Human Mammary Epithelial Cell HMER HMECs overexpressing ras oncogene IGF/R Insulin-like Growth Factor/Receptor IHC ImmunoHistoChemistry INT MMTV Integration gene (M. musculus) LCIS Lobular Carcinoma In Situ (Breast) LDLR Low-Density Lipoprotein Receptor LH Luteinizing Hormone LOH Loss-Of-Heterozygosity LRP LDLR Related Protein MAD Mothers against decapentaplegic (D. melanogaster) vii MAPK Mitogen-Activated Protein Kinase MEOX2 MEsenchymal homeobOX-2 MMTV Mouse Mammary Tumor Virus NDP Norrie Disease Protein NGF Nerve Growth Factor Nov Nephroblastoma overexpressed PPAR Peroxisome Proliferator-Activated Receptor PC Pearson’s Coefficient PCP Planar Cell Polarity (Wnt signaling pathway) PI3K PhosphoInositide-3 Kinase P/S Penicillin/Streptomycin PTCH Patched PTEN Phosphatase and TENsin homolog RPTEC Renal Proximal Tubule Epithelial Cells RCC Renal Cell Carcinoma RCC-Clear RCC-Clear Cell Type rh recombinant, human R-Smad Regulatory-Smad RT-CES Real Time-Cell Expansion System® (ACEA Biosciences) sFRP secreted Frizzled-Related Protein SBE Smad Binding Element SDS Sodium Dodecyl Sulfate viii SDS-PAGE SDS-PolyAcrylamide Gel Electrophoresis Smad Mothers against decapentaplegic and SMA family Member (Common name for MAD and SMA homologs) SNP Single Nucleotide Polymorphism SOST SclerOSTin SOSTDC1 SclerOSTin Domain-Containing 1 (H. sapiens) TCF/LEF T-Cell Factor/Lymphoid Enhancing Factor TGF-β Transforming Growth Factor-β TMA Tissue MicroArray Tsg twisted gastrulation UEP UnExtended Primer USAG-1 Uterine Sensitization-Association Gene-1 (R. Norvegius) VHL Von Hippl-Lindau vWF von Willebrand Factor WAGR Wilms tumor, Aniridia, Genitourinary malformation, and mental Retardation syndrome Wg Wingless (D. melanogaster) WIF Wnt Inhibitory Factor WISP Wnt Inducible Signaling Pathway Wnt Wingless-type MMTV integration site family member (Common name for Wg and INT homologs) ix WT Wilms Tumor locus YRU Population of Nigeria residents with Yoruban ancestors (HapMap designation) x LIST OF ILLUSTRATIONS CHAPTER I Figure Page 1. Amino acid composition of SOSTDC1 22 2. CTCK motif in various secreted signaling molecules 25 3. SOSTDC1 alignment with sclerostin 26 CHAPTER II Figure Page 1. Downregulation of Human SOSTDC1 mRNA in 52 Kidney Tumors 2. Immunohistochemical analysis of SOSTDC1 expression In normal kidney and renal cancer subtypes 55 3. Quantification of SOSTDC1 staining 58 4. Normal human SOSTDC1 is secreted and binds to matrix or cell surface proteins around neighboring cells 60 5. rhSOSTDC1 antagonizes the production of phosphorylated Smad in response to BMP-7 signaling 62 6. SOSTDC1 antagonizes Wnt-3a signaling in renal carcinoma cells 64 7. Overexpression of SOSTDC1 suppresses proliferation of 769-P RCC-clear cell cultures 66 Table Page I. Quantitation of SOSTDC1 Immunohistochemistry 56 xi CHAPTER III Figure Page 1. SOSTDC1 Locus 85 2. Genes in 2 Mbp Region of Interest on 7p 86 3. LOH Results